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1. Introduction
1.1. Central nervous system injury
Traumatic brain injury (TBI) and spinal cord injury (SCI) are serious health problems in
society. It  is estimated that approximately 1.7 million TBI (Ghajar, 2000) and 12,000 new
cases of SCI (https://www.nscisc.uab.edu, 2011) occur each year in the U.S. TBI is the leading
cause of death and permanent severe neurological disabilities in individuals aged below 45
years in the western world. Similarly, SCI affects young adults with an average age of 40.7
years,  and  is  predominantly  caused  by  motor  vehicle  accidents.  Both  types  of  central
nervous system (CNS) injuries commonly result in significant sensorimotor deficits as well
as  psychological  and  cognitive  impairments.  The  associated  social-economic  burden  is
significant.
1.2. Peripheral nervous system injury
Peripheral  nervous  injuries  (PNI)  are  most  primarily  caused  by  traffic  accident,  bone
fractures and joint dislocations (Millesi et al., 1998). Additionally, complications of region‐
al  anesthesia  and  some  neuropathic  or  metabolic  disorders  may  also  cause  PNI.  The
incidence is around 2.8% of trauma patients per year. Injuries to the peripheral nerves may
lead to partial or complete loss of sensory, motor or autonomic functions that can serious‐
ly compromise the life quality of the patients and result in significant socioeconomic loss
(Noble et al., 1998; Taylor et al., 2008).
© 2013 Gao et al.; licensee InTech. This is a paper distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
1.3. current neural tissue engineering
1.3.1. Tissue engineering for the repair of central nerve injury
CNS injuries are characterized by the permanent loss of neural tissues as the result of apoptosis,
axonal damage, as well as acute and chronic neural degeneration. These primary and secon‐
dary neuropathological cascades lead to severe destruction of neuronal circuitry. Subsequent
significant astrogliosis may also constitute a microenvironment that is inhibitory to regener‐
ation. The capacity for self-repair within the adult CNS after injury is poor, and numerous
reparative strategies have been developed to enhance axonal regrowth, reactivate the plasticity
of the spared neural tissue, and replace lost tissue by means of cell transplantation (Kim et al.,
2012). Of these, neural bioengineering adopts a multifaceted approach in providing both a
permissive microenvironment and a suitable three-dimensional scaffold that integrates
transplantable cells with bioactive factors. By modifying the components, morphology, and
architecture of biodegradable and biocompatible materials, a number of scaffolds have been
developed to tailor to the desired physical and chemical properties required for neural repair.
Both natural and artificial polymers such as collagen, chitosan, PLGA (poly lactic-co-glycolic
acid ), and nanofiberous scaffold have been tested in TBI and SCI models (Peter et al.,2009;
Wang et al.,2011). When combined with engrafted stem cells and surface modification, these
bioengineered scaffolds represent some of the most promising materials in neuro-regenerative
therapy. A wide range of transplantable cells have been used in combination with these
scaffolds, including embryonic stem cells, neural stem cells, mesenchymal stem cells, Schwann
cells and a variety of adult multipotent stem cell types. The underlying principle is that these
engrafted cells may promote neural repair and regeneration by means of growth factor
production, neuronal replacement and remyelination. Similarly, enhancement with integrated
bioactive factor or oligopeptide motifs may provide a more conducive environment for the
survival of the engrafted cells and their integration with the host tissue-scaffold. More
importantly, novel controllable release techniques can potentially facilitate the delivery of
embedded tissue factors that counteract or neutralize the local inhibitory signals, and degrade
glioscar. Given the complexity in anatomical organization and functional communication
within the CNS, bioengineered scaffold-based is an reparative strategy of significant potential.
1.3.2. Tissue engineering for repair of peripheral nerve injury
When compared with the CNS, the PNS has a much greater capacity for regeneration after
traumatic injury. For lesion gaps of over 5cm in length, autologous nerve grafting is a treatment
of choice. However, the recovery of sensory and motor function is often slow and incomplete.
Nerve grafting is limited by the availability of the donor nerve, the loss of donor nerve function,
and the additional surgical trauma and complications (Gordon et al., 2003). Peripheral nerve
is mainly constituted by fascicles of myelinated and unmyelinated nerve fibers as well as
multiple layers of connective tissue and blood vessels. PNS bioengineering approaches
therefore require longitudinally orientated conduits to provide the physical support and
contact guidance for neurite regrowth, while maintaining the biological and functional
viability of the distal denervated targets during the regenerative process. The ultimate goal of
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PNS bioengineering is to develop bioengineered nerve implant that could match or exceed the
performance of autograft. Currently, various conduits made of diverse synthetic or natural
biomaterials have been exploited to bridge experimental nerve transection gaps of between
10mm and 80mm in experimental rodent and primate models. The most commonly used
biomaterials are biodegradable polymers such as PLGA, type I Collagen and chitosan. The
engrafted cells may include Schwann cells, neural stem cells and olfactory ensheathing cells
(OECs). However, the degree of axonal regeneration and functional recovery has so far been
found to be limited, and inferior to nerve grafting control. Further studies are required to
explore the applications of other novel materials. (Battiston et al., 2009).
1.4. Biomaterials developed in the field of Neural Tissue Engineering
Various promising biomaterials have been exploited to meet the diverse needs for specific
bioengineering applications. The fundamental requirements of biomaterials utilized in neural
tissue engineering include biodegradability, neural bioactivity and neural tissue-matched
mechanical module.
1.4.1. Biological biomaterials
These are mainly natural polymers such as collagen, laminin, fibronection, fibin, hyaluronic
acid. agarose, alginate, and chitosan. The majority of them are derived directly from ECM and
have been extensively studied due to their inherent merits including the presentation of
biological receptor-binding ligands, the susceptibility to proteolytic degradation and remod‐
eling in vivo (Ma et al., 2008). These natural macromolecules can be hydrated, and serve as
bioscaffolds for various cells in vivo and in vitro. For example, collagen is the most abundant
protein from natural ECM in connective tissue. In mammalian tissues, the primary structural
collagen is type I collagen. The collagen conduit made of type 1 collagen such as NeuraGen
conduit has been approved by the United States Food and Drug Administration (FDA) and is
commercially available for clinical use practice, whereas limited in field of the peripheral nerve
repair (Kehoe et al., 2012). Major concerns regarding the clinical application of biologically
derived materials, include the problems with sustainable production, immunogenicity, and
pathogen transmission as well as weak mechanical in vivo strength.
1.4.2. Artificial biomaterials
Compared to the natural polymers, artificial biomaterials or biomimetic materials, could be
designed and synthesized to mimic one or multiple desired characteristics of the natural ECM
for specific purposes. For reparative applications, artificial polymers have the advantages of
having great flexibility for design and modification so as to allow for the control of orientation
and development of new-born tissue for better functional outcomes.
1.4.2.1. Degradable materials
Biodegradability is an important property of biomaterials in tissue engineering. Due to the
well-accepted biodegradability and biocompatibility, linear aliphatic polyesters including
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poly(lactic acid) (PLA), poly(glycolic acid) (PGA), and their copolymers poly(lactic acid-co-
glycolic acid) (PLGA) have been widely utilized to reconstruct bioscaffold in diverse condi‐
tions of neural repair. To facilitate host-material integration, biomaterial candidates must also
possess the appropriate elastic module. For instance, hydrogel made of poly(2-hydroxyethyl
methacrylate-co-methyl methacrylate) (p(HEMA-co-MMA)) has similar mechanical proper‐
ties to the mammalian spinal cord (elastic modulus of 200 to 600 kPa), and could be customized
by altering the ratio of co-monomers (Dalton et al.,2002). The hydrophobic surface properties
in most of the synthetic biodegradable materials such as PLGA, PCL and PHB, may be modified
by coating them with ECM proteins components like laminin, fibronectin, collagen. Specific
adhesion oligopeptide such as RGD and IKVAV, YIGSR may also be added to improve their
adhesion properties for seeded cells. Several studies showed that the cellular adhesion
performance of these artificial biomaterials including methyl cellulose, alginate, poly (hy‐
droxyethyl methacrylate) (PHEMA), poly (hydroxybutyrate) (PHB) (Samadikuchaksaraei,
2007), could be significantly improved by surface modifications. Another category of synthetic
biomaterial is related to the nanofibre scaffold which will be discussed in later sections.
1.4.2.2. Nondegradable materials
The use of synthetic nondegradable materials in neural repair is limited by their nondegrada‐
blilty and unbioabsorbility. The majority of reported studies involved PNI. For example, poly
(2-hydroxyethyl methacrylate) has been demonstrated to support regeneration of injured
axons in a rat SCI model (Tsai et al. 2006). Recently, electroactive polymer like polypyrole or
hybrid conduct materials showed neuronal attachment and growth. The major concerns
regarding these materials are related to immunorejection, chronic inflammatory responses,
fibrous scarring, and the associated problems of neural compression and need for re-operation.
These render nondegradable materials unsuitable for CNS repair (Cullen et al., 2008).
2. Nanofibrous scaffolds applied in CNS regeneration
2.1. Current fabrication of nanofiber-based bioscaffolds used in CNS regeneration
The aim of biomedical engineering is the design and development of novel biomaterials that
can recapitulate the key characteristics of natural ECM with the associated topographical cues,
cellular adhesion sites, biochemical signals and physiological viscoelastic modules. In general,
extracellular proteins such as collagen, fibrin and glycosaminoglycans, possess fibrous
structures with diameters on the nanometer or sub-micrometer scales. Several bioengineering
approaches have been developed for the fabrication of artificial nanofibre constructs with
diameters that range from 10 to 100nm.
2.1.1. Self-assembling peptide nanofiber scaffolds (SAPNS)
Many biological macromolecules such as like phospholipids can readily self-assemble to form
highly ordered bio-structures through van der Waals forces, hydrogen bonds, ionic bonds, and
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hydrophobic interactions. To recapitulate the bioactive motif of laminin, Stupp and coworkers
designed a self-assembling peptide amphiphile (PA) that consisted of the laminin-derived
peptide IKVAV (Ile-Lys-Val-Ala-Val). The self-assembly of IKVAV could be initiated sponta‐
neously upon the introduction of physiological buffer which leads to the formation of
nanofibers with diameter ranging from 6 to 8 nm (Tysseling-Mattiace, 2008).
2.1.2. Eletrospun nanofiber scaffolds
Electrospinning was a traditional industrial fabrication technique used widely in 1930s. Due
to its effectiveness of producing microfibers with diameters of sub-micron or nanometer scale,
it has been utilized to process a number of natural and synthetic polymers such as collagen,
fibroin, PLLA, PLGA, and PCL. The electrospun nanofiber matrices resemble the structural
morphology of ECM with a high surface area–to-volume ratio, which has been shown to
greatly facilitate cellular attachment, proliferation and differentiation. Recent studies continue
to report the development of novel electrospun nanofibers, and the introduction of bioactive
molecules such as growth factors during the fabrication process of nanofibers for peripheral
nerve regeneration (Prabhakaran et al., 2008). The intrinsic limitations of this technique include
the degradation of bioactive factors during procedure, the inability to fabricate complex 3D
structures or specific microstructure with designed internal pore size.
2.1.3. Phase separation
Phase separation, or thermally induced liquid–liquid phase separation, was developed by Ma
and Zhang to produce a nanofibrous foam materials. Polymer scaffolds generated by phase
separation normally have a sponge-like porous morphology with spherical pores 50–500 nm
in diameter. Phase separation system consists of a polymer-rich component and a polymer-
lean/solvent-rich component, by which the polymer morphology can solidify by quenching
under low temperature. A few nanofibre scaffold from artificial biodegradable polymers have
been produced with phase separation including PLLA, which was studied as a suitable
matrices in which NSCs can grow and differentiate (Yang et al., 2004). Compared with other
techniques previously discussed phase separation has simpler and the need for specialized
equipment is minimal. However, due to the small number of candidate polymers suitable for
in vivo study, reports on nanofiber scaffold generated by phase separation in neural tissue
engineering are limited.
2.2. Current application of SAPNS for the repair of injured CNS
2.2.1. Traumatic brain injury
The applications of RADA16-I, a representative SAPNS, in 3D cell culturing, wound hemo‐
stasis and healing has been well described in a series of studies. The initial research of RADA16-
I in experimental TBI was conducted by Ellis-Behnke et al. (Ellis-Behnke et al. 2006). Using an
acute TBI model in which the midbrain of P2 hamsters was injured surgically with a knife
wound (1.5 mm deep and 2.0 mm wide), 10μl of 1% SAPNS was applied to bridge the injury
gap. The central traumatic lesion showed restoration in all SAPNS-treated animal subjects
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within the first 24-hour and at all other timepoints up to 30 days post-injury. Compared with
saline-treatment, SAPNS created a seamless connection across lesion site and appropriate host-
scaffold interfaces which led to significantly improved repair. Further studies were conducted
by Guo et al. using a rodent TBI model (Guo et al., 2009). Immediately after the infliction of
severe mechanical injury to the sensory-motor cortex, 20 μL of 1% RADA16-I SAPNS was
implanted at the lesion sites to bridge the injury gap. Histological, immunohistochemical and
apoptosis studies were performed at 2 days, 2 weeks, and 6 weeks after injury. The SAPNS-
treated lesion sites had no cyst formation after injury and showed integrated host-scaffold
interfaces; saline-treatment resulted in significant cyst formation. Moreover, SAPNS signifi‐
cantly reduced apoptosis in the perilesional area and effectively mitigated reactive gliosis and
inflammation. Currently, a few integrative strategies of SAPNS incorporated with bioactive
factors have been conducted with an aim to improve functional recovery after severe TBI.
2.2.2. Spinal cord injury
A variety of biodegradable hydrogel have been extensively studied in the treatment of
experimental SCI. IKVAV peptide amphiphile, which consists of neuroactive pentapeptide
epitope from laminin, has been applied in a moderate spinal cord contusion model in which
1% aqueous solution of IKVAV-SAPNS was injected into the lesion sites 24h after injury.
IKVAV-SAPNS significantly reduced the degree of oligodendroglial apoptosis perilesion and
enhanced their survival rate with cleaved caspase-3 immunohistochemistry at 10 d after SCI.
Additionally, astrogliosis was reduced significantly and the regeneration of motor-sensory
axons were improved remarkably on BDA-labeling 11 week after treatment. Moreover, at 9wks
after treatment, the mean locomotor score of IKVAV-SAPNS group was significantly better
than that of the control group on BBB score measurement, and dorsal stepping was observed
with IKVAV-treatment, indicating functional return in hindlimb movement (Tysseling-
Mattiace, 2008).
One of the most important advantages of SAPNS is its ability to provide a 3-D matrice in which
neural cells can survive and differentiate. Guo and coworkers incorporated neural stem cells
(NSCs) and Schwann cells in SAPNS, and transplanted them into dorsal column lesion of the
cervical spinal cord. At 6 wks after implantation, there was excellent integration between the
implant and the host tissue. Moreover, extensive axonal regrowth was observed with immu‐
nohistochemistry staining with NF, 5-HT, and CGRP (Guo et al., 2007). Recent reports
highlighted the further applications of controlled release of bioactive factors incorporated into
the SAPNS in vitro and in vivo. For instance, CT04, a cell permeable RhoA inhibitor, was
incorporated into RADA16-I-SAPNS and implanted in a complete transection lesion at T9 level
of the spinal cord. This novel integrative SAPNS not only reconstructed the injured nerve gap,
but also elicited significant axonal regeneration and motor functional recovery. Additionally
it also effectively reduced the infiltration and apoptosis of activated macrophages within the
injured spinal cord. The SAPNS-based delivery of RhoA inhibitor is a potentially effective
therapeutic strategy by reknitting lesion gap, attenuating secondary injury and improving
axonal regeneration (Fig.1). Moreover, Gelain and Zhang’s group has developed functional‐
ized SAPNS that can improve the engraftment and neural differentiation of seeding neural
Advances in Nanofibers190
progenitor cells in vitro, and enhance neural regeneration in vivo. With the aid of phage display
technology, a functionalized SAPNS was found to demonstrate high in vitro stem cell viability
and neural differentiation, as well as significantly promoted axonal regrowth and locomotor
functional recovery in acute spinal cord injury (Gelain et al., 2006; 2012).
Collectively, these in vivo studies with various SCI models evidenced the significant potential
of SAPNS in the repair of SCI from different aspects that SAPNS provide. Based on the current
advances of fabrication and biochemistry techniques, future directions would consider
introduction of updated topographical cues and more bioactive motifs or growth factors into
the scaffold design to induce more robust and organized regeneration for injured central neural
system, achieving more significant functional recovery.
3. Nanofibrous scaffolds applied in PNS repair
3.1. Development of nanofiber biomaterials used for PNS regeneration
A variety of biodegradable materials have been processed into nanofibrous scaffold using
eletrospining technique for PNI repair (Xie et al., 2010). In an early study, a bilayer chitosan
conduit with inner layer of nano/microfibrous structure modified with oligopeptide was
generated  to  repair  a  15mm  sciatic  nerve  gap  in  rats  (Wang  et  al.,  2008).  This  novel
integrative  chitosan  conduit  effectively  promoted  the  axonal  regeneration  that  was
comparable to that of  autologous nerve grafting? on histological  assessment.  Recently,  a
blend of  biodegradable  polymers  PLGA/PCL was used to  produce electrospun tubes  to
bridge a 10mm long sciatic nerve lesion gap in rat. Four months after surgery, most of the
electrospin  conduit-treated  animals  showed  neural  regeneration  and  functional  restora‐
tion on immunohistochemial  studies  and electrophysiological  assessment  (Panseri  et  al.,
2008).  More  interestingly,  a  novel  bi-layer  nanofibrous  nerve  conduit  made  of  poly  (L-
lactide-co-caprolactone) and poly(propylene glycol)  has been fabricated with electrospin‐
ning technique for PNI repair. The electrospin nerve conduit was designed as the luminal
layer composed of longitudinally aligned nanofibers to promote axon regeneration, while
the outer layer was equipped with random- organized nanofibers for mechanical support.
After being implanted to bridge a 10mm gap of sciatic nerve, the nanofibrous nerve conduit
significantly improved the regeneration of injured peripheral axons and motor functional
recovery at 2 and 12 month post-surgery (Zhu et al.,  2011).  More recently, the effects of
fibre diameter of electrospun conduits on peripheral nerve regeneration was analyzed with
a 15mm sciatic  nerve injury model.  These fibrous conduits  consisted of  aligned electro‐
spun poly (ε-caprolactone) (PCL) nanofibers (251±32 nm) and microfibers (981±83 nm). The
nanofiber-treated group showed significantly greater total number of myelinated fibers and
thicker  myelin  sheaths  when  compared  with  groups  that  received  Microfiber  and  Film
conduits  at  3  month  post-treatment.  The  number  of  regenerated  dorsal  root  ganglion
neurons  in  animals  that  received  nanofiber  conduits  was  increased  significantly  by
retrograde labeling with fluorogold. On electrophysiological testing including compound
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muscle  action  potential  and  distal  motor  latency,  the  nanofibre-group  showed  greater
improvement  than the  microfiber  group (Jiang et  al.,  2012).  These  positive  observations
provide useful insights for the applications of electrospun nanofibrous nerve conduits with
designed nanostructure in the development of peripheral nerve guide conduits.
3.2. Reconstruction of injured PNS with SAPNS
SAPNS has a well-defined sequence of L-amino acids that self-assemble under physiologi‐
cal conditions to form a fibrous scaffold within the nanoscale (∼10 nm in diameter). In the
recent decades,  SAPNS has been shown to facilitate the survival  and growth of  various
neural  cells  within  a  3D matrice,  and effectively  improved the  axonal  regeneration and
tissue repair in context of CNS injuries. It also has significant potential for PNI repair. For
example, a novel SAPNS-based nerve conduit was generated by RAD-I SAPNS ensheath‐
ed with a segment of aortic wall. With a sciatic nerve transection model of rat, the SAPNS-
nerve conduit was used to bridge a 10mm nerve gap. Neural histomorphology, retrograde-
labeling and locomotor functional assessments demonstrated significant therapeutic effects
of  SAPNS-based  nanofiber  conduit  implant  on  axonal  regeneration,  remyelination  and
target reinnervation (Fig.2,). Additionally, SAPNS acts as a designer peptide backbone and
provides the opportunity to integrate various growth factor, or functional motifs for cell
adhesion, differentiation and homing, and to define and direct biological commitment of
seeding  cells;  furthermore,  functional  SAPNS  will  provide  better  support  for  viability,
migration and differentiation of engrafted stem cells in vivo and lead to better perform‐
ance of neural repair in vivo.
4. Conclusion
The functional repair of peripheral and central nervous system injuries is a major challenge.
Based on the advances of development of novel biomaterials, biochemistry and fabrication
techniques, bioengineered scaffold enhanced with bioactive motifs and engrafted cells can
provide a regeneration-facilitating environment for injured nervous tissues, and effectively
promote the host’s capacity of neural regeneration and plasticity. Numerous in vitro models
have demonstrated that 3-D bioscaffold, in particular the nanofibre scaffold, can greatly
support the attachment, proliferation, migration and neural differentiation of various neural
cells. Moreover, significant neuroprotection and axonal regeneration have been achieved in
in vivo neural injury models after treatment with these novel scaffolds. More importantly, the
recovery of injured sensory and locomotor function has been shown to occur in a number of
peripheral and central injury models using different animal species. However, critical issues
such as functional integration of host-implant, organized regeneration pattern with updated
bioengineering scaffolds and further restoration of useful neurology function, remain to be
addressed in future researches.
Immunohistochemistry with Neurofilament(NF) staining showed a number of NF-positive
axons (Green)penetrated into the lesion sites with SAPNS+CT04 treatment(A). Counterstained
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DAPI area (blue) indicated the gross structure of the injured spinal cord. (B) is the high power
magnification corresponding to the boxed area of (A) demonstrated the NF-positive axons in
the center of lesion area. Quantification analysis of the NF-positive axons in the center of the
lesion area indicated that axonal regeneration was significantly improved by the SAPNS+CT04
implants compared to the only SAPNS group (Student t test, *p<0.05).
Figure 1. Axonal regeneration in the SAPNS-treated groups.
With NF/MBP-double immunofluoresent labeling, in sharp contrast to that of Empty Nerve
Conduit (ENC) group (A-C), significant remyelination of regenerated axons was detected
throughout the entire Nanofiber Nerve Conduit (NNC) 16 weeks after treatment (D-F).
Representative transverse sections of proximal, middle and distal parts of Nerve Conduit (NC)
were demonstrated at panel (A, D), (B, E), and (C, F) in ENC and NNC group, respectively.
(G) is the higher magnification of boxed area of (E) with arrows indicating the representative
remyelinated fibers. Furthermore, with electron microscopy, typical remyelinated fibers
(arrowheads) could be found in both NC groups, while the diameter of the fiber and the
thickness of the myelin are greater in NNC (H) compared with ENC (I). (J,K) showed the
quantification analysis of the myelinated fiber caliber and the G-ratio ( an index of myelin
thickness) separately. Both comparisons using student’s t test indicated significantly statistical
differences (*p<0.05;**p<0.01).
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Figure 2. Remyelination of regenerated axons in the peripheral nerve conduits
Author details
Mingyong Gao1,7, Jiasong Guo5, Gilberto K. K. Leung6 and Wutian Wu1,2,3,4
1 Department of Anatomy, Li Ka Shing Faculty of Medicine, The University of Hong Kong,
Hong Kong SAR, China
2 State Key Laboratory of Brain and Cognitive Sciences, China
3 Research Center of Reproduction, Development and Growth, Li Ka Shing Faculty of Medi‐
cine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China
4 Joint Laboratory for Brain Function and Health (BFAH), Jinan University and The Univer‐
sity of Hong Kong, Guangzhou, China
5 Department of Histology and Embryology, Southern Medical University, Guangzhou,
China
6 Department of Surgery, Li Ka Shing Faculty of Medicine, The University of Hong Kong,
Pokfulam, Hong Kong SAR, China
7 Department of Orthopeadics, Renmin hospital of Wuhan University, Wuhan, China
Advances in Nanofibers194
References
[1] Battiston B, Raimondo S, Tos P, Gaidano V, Audisio C, Scevola A, Perroteau I, Geuna
S. Tissue engineering of peripheral nerves. Int Rev Neurobiol. 2009; 87: 227–49.
[2] Chen VJ, Wei G, Ma PX, Nanostructured scaffolds for tissue engineering and regen‐
eration, in: H.S. Nalwa (Ed.), Handbook of Nanostructured Biomaterials and Their
Applications in Nanobiotechnology,vol. II, American Scientific Publishers, Stevenson
Ranch, California, 2005; 415–35.
[3] Cullen DK, R Patel A, Doorish JF, Smith DH, Pfister BJ. Developing a tissue-engi‐
neered neural-electrical relay using encapsulated neuronal constructs on conducting
polymer fibers. J Neural Eng. 2008;5(4):374-84.
[4] Cunha C, Panseri S, Antonini S.Emerging nanotechnology approaches in tissue engi‐
neering for peripheral nerve regeneration. Nanomedicine. 2011; 7(1):50-9.
[5] Dalton PD, Flynn L, Shoichet MS. Manufacture of poly(2-hydroxyethyl methacrylate-
co-methyl methacrylate)hydrogel tubes for use as nerve guidance channels. Biomate‐
rials. 2002; 23(18):, 3843-51.
[6] Deumens R, Bozkurt A, Meek MF, Marcus MA, Joosten EA, Weis J, Brook GA. Re‐
pairing injured peripheral nerves: Bridging the gap. Prog Neurobiol. 2010; 92(3):
245-76.
[7] Ellis-Behnke RG, Liang YX, You SW, Tay DK, Zhang S, So KF, Schneider GE.. Nano
neuro knitting: peptide nanofi ber scaffold for brain repair and axon regeneration
with functional return of vision. Proc. Natl. Acad.Sci. USA. 2006; 103(13): 5054–9.
[8] Gelain F, Bottai D, Vescovi A, Zhang S. Designer self-assembling peptide nanofiber
scaffolds for adult mouse neural stem cell 3-dimensional cultures. PLoS ONE. 2006;
e119:1.
[9] Gelain F, Cigognini D, Caprini A, Silva D, Colleoni B, Donegá M, Antonini S, Cohen
BE, Vescovi A.New bioactive motifs and their use in functionalized self-assembling
peptides for NSC differentiation and neural tissue engineering. Nanoscale. 2012;4(9):
2946-57.
[10] Ghajar J. Traumatic brain injury. Lancet. 2000; 356(9233):923-9.
[11] Gordon T, Sulaiman O, Boyd JG., Experimental strategies to promote functional re‐
covery after peripheral nerve injuries. J Peripher Nerv Syst. 2003; 8(4): 236-50.
[12] Guo J, Leung KKG, Su H, Yuan QJ, Wang L, Chu TH, Zhang W, Pu JKS, Ng GKP,
Wong WM, Dai X, Wu WT.. Self-assembling peptide nanofi ber scaffold promotes the
reconstruction of acutely injured brain.Nanomedicine. 2009; 5(3): 345–51.
Use of Self-Assembly Nanofibre Biomaterials for Neural Repair After Injury
http://dx.doi.org/10.5772/57098
195
[13] Guo J, Su H, Zeng Y, Liang YX, Ellis-Behnke RG, So KF, Wu W. Reknitting the in‐
jured spinal cord by self-assembling peptide nanofi ber scaffold. Nanomedicine 2007;
3(4): 311–21.
[14] Jiang X, Mi R, Hoke A, Chew SY. Nanofibrous nerve conduit-enhanced peripheral
nerve regeneration. J Tissue Eng Regen Med. 2012 Jun 15. [Epub ahead of print]
[15] Keeley RD, Nguyen KD, Stephanides MJ, Padilla J, Rosen JM. The artificial nerve
graft: a comparison of blended elastomer-hydrogel with polyglycolic acid conduits. J
Reconstr Microsurg 1991;7(2):93-100.
[16] Kehoe S, Zhang XF, Boyd D. FDA approved guidance conduits and wraps for pe‐
ripheral nerve injury: a review of materials and efficacy. Injury. 2012; 43 (5):553-72.
[17] Kim H, Cooke MJ, Shoichet MS. Creating permissive microenvironments for stem
cell transplantation into the central nervous system. Trends Biotechnol. 2012; 30(1):
55-63.
[18] Ma PX. Biomimetic materials for tissue engineering. Adv Drug Deliv Rev. 2008;
60(2): 184–98.
[19] Millesi H. Trauma involving the brachial plexus. In: Omer GE, Spinner M, Van Beek
AL, eds. Management of Peripheral Nerve Problems. Philadelphia: Saunders;
1998;433–44.
[20] Noble J, Munro CA, Prasad VSSV, Midha R. Analysis of upper and lower extremity
peripheral nerve injuries in a population of patients with multiple injuries. J Trauma.
1998; 45(1): 116-22.
[21] Panseri S, Cunha C, Lowery J, Del Carro U, Taraballi F, Amadio S, Vescovi A, Gelain
F. Electrospun micro- and nanofiber tubes for functional nervous regeneration in sci‐
atic nerve transections. BMC Biotechnol. 2008; 8:39.
[22] Prabhakaran MP, Venugopal JR, Chyan TT, Hai LB, Chan CK, Lim AY, Ramakrishna
S. Electrospun biocomposite nanofibrous scaffolds for neural tissue engineering. Tis‐
sue Eng Part A. 2008;14(11):1787-97.
[23] Raimondo S, Fornaro M, Tos P, Battiston B, Giacobini-Robecchi MG, Geuna S. Per‐
spectives in regeneration and tissue engineering of peripheral nerves. Ann Anat.
2011,193(4):334-40.
[24] Samadikuchaksaraei A. An overview of tissue engineering approaches for manage‐
ment of spinal cord injuries. J Neuroeng Rehabil. 2007; 4: 15.
[25] Toba T, Nakamura T, Lynn AK, Matsumoto K, Fukuda S, Yoshitani M, Hori Y, Shi‐
mizu Y. Evaluation of peripheral nerve regeneration across an 80-mm gap using a
polyglycolic acid (PGA)--collagen nerve conduit filled with laminin-soaked collagen
sponge in dogs. Int J Artif Organs. 2002; 25(3):230-7.
Advances in Nanofibers196
[26] Taylor CA, Braza D, Rice JB, Dillingham T. The incidence of peripheral nerve injury
in extremity trauma. Am J Phys Med Rehabil, 2008; 87(5): 381-85
[27] Tsai EC, Dalton PD, Shoichet MS, Tator CH. Matrix inclusion within synthetic hydro‐
gel guidance channels improves specific supraspinal and local axonal regeneration
after complete spinal cord transection. Biomaterials. 2006; 27(3):519-33.
[28] Tysseling-Mattiace VM, Sahni V, Niece KL, Birch D, Czeisler C, Fehlings MG, Stupp
SI, Kessler JA.
[29] Self-assembling nanofibers inhibit glial scar formation and promote axon elongation
after spinal cord injury. J Neurosci. 2008;28(13):3814-23.
[30] Walker PA, Aroom KR, Jimenez F, Shah SK, Harting MT, Gill BS, Cox CS Jr.. Advan‐
ces in progenitor cell therapy using scaffolding constructs for central nervous system
injury. Stem Cell Rev. 2009; 5(3): 283–300.
[31] Wang M, Zhai P, Chen X, Schreyer DJ, Sun X, Cui F. Bioengineered scaffolds for spi‐
nal cord repair. Tissue Eng Part B. 2011;17(3):177-94.
[32] Wang W, Itoh S, Matsuda A, Aizawa T, Demura M, Ichinose S, Shinomiya K, Tanaka
J.Enhanced nerve regeneration through a bilayered chitosan tube: the effect of intro‐
duction of glycine spacer into the CYIGSR sequence. J Biomed Mater Res A. 2008;
85(4): 919-28.
[33] Xie J, MacEwan MR, Schwartz AG, Xia Y. Electrospun nanofibers for neural tissue
engineering. Nanoscale. 2010; 2(1):35-44.
[34] Yang F, Murugan R, Ramakrishna S, Wang X, Ma YX, Wang S. Fabrication of nano-
structured porous PLLA scaffold intended for nerve tissue engineering. Biomaterials
2004; 25(10):1891-900.
[35] Zhu Y, Wang A, Patel S, Kurpinski K, Diao E, Bao X, Kwong G, Young W, Li S. Engi‐
neering Bi-layer Nanofibrous Conduits for Peripheral Nerve Regeneration. Tissue
Eng Part C Methods. 2011; 17(7):705-15.
Use of Self-Assembly Nanofibre Biomaterials for Neural Repair After Injury
http://dx.doi.org/10.5772/57098
197

